The A7(74) strain of Semliki Forest virus (SFV) is avirulent and the L10 strain virulent in adult mice. A7(74) infection of adult mouse brain gives rise to small discrete foci of infection which, in immunocompetent animals, are cleared within 10 days. In contrast L10 infection results in a widespread and fatal central nervous system infection. Aurothiolates are linear, 2-coordinate complexes in which two ligands are covalently bound on either side of a gold nucleus in a +1 oxidation state (gold (I)). Pretreatment of A7(74) infected mice with two distinct aurothiolates (sodium aurothiomalate and aurothioglucose) resulted in signi®cantly increased brain virus titers, and large con¯uent areas of infection in the brain similar to the pattern of infection seen with the L10 strain. The gold (I) moiety of aurothiolates was demonstrated to be the active component, since thiomalic acid when administered alone had no potentiating effect on the infection. Although both aurothiolates allowed productive replication and spread of A7 (74) within the nature mouse brain, enhanced neuronal destruction was not apparent. There were no signi®cant changes in virus distribution in any other tissue except for the exocrine pancreas and the myocardium where widespread infection of the acinar cells and occasional infected myocytes were observed.
Introduction
Semliki Forest virus (SFV) is a well characterized neurotropic alphavirus. A number of strains, differing in their virulence for mice have been isolated from mosquitoes. Amongst these is a virulent L10 strain, isolated from a pool of Aedes abnormalis mosquitoes captured in Uganda (Smithburn and Hadow, 1944) and an avirulent strain, A7(74), derived from Aedes argenteopunctatus mosquitoes caught in Mozambique (McIntosh et al, 1961; Bradish et al, 1971) . Following intraperitoneal (ip) inoculation into 3 ± 4-week-old mice, L10 produces a lethal encephalitis which results in death within 6 days. In contrast A7(74) causes a subclinical encephalitis characterized by restricted virus replication and survival of infected central nervous system (CNS) neurons Amor et al, 1996) . Both humoural and cell-mediated immune responses contribute to the clearance of A7(74) from the CNS, but do not account for the focal nature of this infection, since the restricted pattern of infection is also observed in adult mice with severe combined immunode®ciency (SCID) Amor et al, 1996) . Clearance of A7(74) in immunocompetent mice coincides with the appearance of temporary lesions of CD8 T-cell mediated demyelination within the CNS (Suckling et al, 1978; Fazakerley and Webb, 1987a,b; SubakSharpe et al, 1993) .
Both strains of SFV have been reported to replicate to similar titers in extraneural tissues, predominantly muscle (Pusztai et al, 1971; Amor et al, 1996) , producing a plasma viraemia which delivers virus to the CNS. In immunocompetent adult Balb/c mice, foci of A7(74) replication in peripheral tissues are dif®cult to ®nd by immunostaining or in situ hybridization, but focal infection of skeletal muscle ®bres has been observed in infected SCID mice (Amor et al, 1996) . SFV is thought to enter the CNS by passage across cerebral vascular endothelial cells Webb, 1974, 1980) . Once within the CNS of adult mice, L10 and A7(74) display very different abilities to replicate and spread . In both instances virus ®rst appears as small foci of infected cells around cerebral capillaries. In the L10 infection virus spreads rapidly from these initial foci to infect large areas throughout the brain. With A7(74) little or no spread occurs from the original perivascular foci. In contrast to this focal CNS infection in 3 ± 4-week-old mice, infection of mice with A7(74) at 12 days of age or less, results in widespread fatal encephalitis Oliver et al, 1997) . This age-related change in virulence is not due to maturity of speci®c immune responses since infection of 3 ± 4-weekold SCID mice remains focal . The inability of A7 (74) to spread in the brains of 3 ± 4-week-old mice has been linked to a restriction of virus replication which is dependent upon the differentiation state of CNS cells Fazakerley et al, 1993; Oliver et al, 1997; Oliver and Fazakerley, 1998) . Despite extensive examination of infected brain tissue under the electron microscope, neither virus particles nor discrete nucleocapsids are observed in CNS cells of adult mice infected with A7(74) (Pathak and Webb, 1988a) . Amorphous and ®brous viral material, described as viral core aggregates (VCA), accumulates in isolated CNS cells (Pathak and Webb, 1988b; Fazakerley et al, 1993) .
It has been demonstrated that treatment of 3 ± 4-week-old mice with the gold compound sodium aurothiomalate (GSTM) prior to inoculation with A7(74) renders this infection lethal (Allner et al, 1974; Bradish et al, 1975; Pathak and Webb, 1983; Mehta and Webb, 1982 , Gates et al, 1984 Mehta et al, 1987 . GSTM is an aurothiolate compound which has been used in the treatment of rheumatoid arthritis. Aurothiolates are linear, 2-coordinate complexes in which two ligands are covalently bound on either side of a gold nucleus in a +1 oxidation state (gold (I)). Early studies suggested these gold compound affected the outcome of SFV infection by an effect on macrophages (Allner et al, 1974; Bradish et al, 1975) . Subsequent studies con®rmed that these compound have an effect on macrophages Webb, 1982, 1990) but suggested that this was not the basis for their effect on the course of SFV infection (Mehta and Webb, 1987; . Electron microscopic studies of CNS cells from mice inoculated ip with GSTM have revealed intracellular deposits, with electron-dense pro®les characteristic of soluble gold salts, con®rming that the drug enters the CNS (Pathak and Webb, 1983) . It has been reported that in the presence of GSTM the restriction on A7(74) virion formation in the mature CNS is relieved (Pathak and Webb, 1983) . In this study we investigate the effect of two aurothiolates, sodium aurothiomalate (GSTM) and aurothioglucose (GSTG) on the pathogenesis of A7(74) infection, and show that increased virulence is associated with enhanced replication and spread of virus in the brain and pancreas. We demonstrate that it is the gold (I) moiety in these compounds which is active in this respect and that aurothiolateenhanced replication of virus in the acinar cells of the exocrine pancreas is associated with apoptotic cell death, but the widespread infection of neurons is not.
Results

Mortality
Forty-two female Balb/c mice (3 ± 4-weeks old) were divided into six groups of seven mice. Two groups were administered 10 mg of GSTM (ip), two groups 10 mg of GSTG (ip). Two groups received no pretreatment. Four hours later one of each of the GSTM and GSTG pre-treated groups was inoculated (ip) with 5610 3 p.f.u. of A7(74). At the same time the two untreated groups were inoculated (ip), one with 5610 3 p.f.u. of L10 and the other with the same quantity of A7(74). The mice were observed daily over the course of 2 weeks for signs of disease. Figure 1 shows the survival of the various groups.
All mice infected with the L10 strain of SFV were dead by 6 days post infection. In contrast, all mice infected with the A7(74) strain survived and no clinical signs were observed over the 2-week observation period. Mice administered GSTM and infected with A7(74) showed signs of hind limb paralysis by post infection day (PID) 4 and were all dead by PID 6. Clearly this compound renders the normally avirulent A7(74) infection virulent. Mice administered 10 mg of GSTM alone, displayed ruf¯ed fur from 3 days and were hunched in appearance during days 6 and 7, one died 8 days after inoculation but the remaining mice survived. Amongst the seven mice administered GSTG and infected with A7(74) one died on PID 5 and another on PID 7, the remaining ®ve survived (overall mortality 29%). In subsequent experiments overall mortality with A7(74) plus GSTG averaged 44% (7/ 16). All of the mice administered GSTG alone maintained a healthy appearance.
To investigate the effect of aurothiolates on the CNS infection a second study was undertaken. Five groups, each comprising 12 ± 18 BALB/c mice (3 ± 4 weeks old), were inoculated with 5610 3 p.f.u. of SFV. One group was infected with the L10 strain, the remaining four groups with A7(74). Two of the A7(74) infected groups had been administered 10 mg doses of GSTM or GSTG 4 h previously. A further group was inoculated with the thiomalic acid (TMA) component of GSTM prior to infection with A7(74), and the fourth group received A7(74) alone. Three mice were sampled from each group at 24 h intervals. For each mouse, the virus titer was determined in one half of the brain by plaque assay and the distribution of virus was determined in the other half by in situ hybridization and autoradiography. In addition, samples of all major peripheral tissues were taken and virus distribution was determined by in situ hybridization and immunostaining. Figure 2 shows brain virus titers in mice infected with either the L10 or A7(74) strain of SFV or infected with the A7(74) strain following administration of aurothiolates. Brain virus titers rose most rapidly in L10 infected mice reaching on average 6610 8 p.f.u./g by PID 4. In A7(74) infected mice, brain virus titers rose more slowly to a maximum of 8610 5 p.f.u./g on PID 6. By PID 3 both strains were detected in the brain of all unpre-treated mice. At this time post infection the strain-dependent difference in the levels of brain virus was most profound. Levels of brain virus were signi®cantly higher (P50.02, Student's two tailed t-test) with L10 than with A7(74), with average titers of 4610 8 p.f.u./g and 1.7610 2 p.f.u./g, respectively. A7(74) was eventually cleared from the brain, with only 1 of 3 mice harbouring detectable virus on PID 9. No virus was detected in the brain of A7(74) infected mice by plaque titration on PID 14 (data not shown).
Brain virus titers
Pre-treatment of 3 ± 4-week-old mice with GSTM or GSTG increased the A7(74) brain virus load by up to 30 000-fold. On PID 4 levels of A7 (74) 
-test).
On days 2, 3 and 4 the GSTG group titers were signi®cantly higher (P50.03) than the GSTM group. Brain virus titers continued to rise in mice administered GSTM up to PID 5. By PID 6 all of the GSTM pre-treated mice were dead. Figure 3 shows the distribution of SFV RNA in representative brain sections from each of the groups of mice. As reported previously , small, randomly distributed foci of viral RNA-positive cells are characteristic of A7 (74) infection in the mature brain. This contrasts with widespread virus-positivity observed in L10 infected mice by PID 5 , and with the widespread nature of A7 (74) infection in the CNS of neonatal mice (Oliver et al, 1997) . Pretreatment with the TMA component of GSTM prior to A7(74) infection had no effect on virus spread (Figure 3 ). Virus-positive cells remained con®ned to perivascular foci. In contrast, pretreatment with either GSTM or GSTG relieved the restriction on the spread of A7 (74); large con¯uent areas of virus-positive cells were observed in the brains of GSTG and GSTM pre-treated mice by PID 5. In line with the normal course of A7(74) CNS infection, virus ®rst appeared in the pre-treated mice as small perivascular foci. However, in the presence of gold compounds A7(74) infection resembled L10 infection, with virus spreading rapidly throughout the brain to create large conuent areas of infection. Brain sections were further examined for viral protein expression and apoptosis of infected cells. Figure 4B ), and in L10 infected mice ( Figure 4C ). Despite, this enhancement of viral replication, there was no increase in the number of TUNEL positive nuclei in the CNS of A7(74) infected mice pre-treated with aurothiolates ( Figure 4D ). In aurothiomalate pre-treated and in L10 infected brain sections, neuronal processes stained positive for viral antigen, but in A7(74) infected brain tissue from non pre-treated mice only viral antigen-positive cell bodies were visible. Both A7(74) and L10 infected neurons had pale, swollen nuclei with prominent nucleoli (Figure 4B and C) .
Central nervous system spread
Infection of peripheral tissues
Random sections of peripheral tissues including heart, lung, liver, gut, pancreas, spleen, thymus, lymph nodes, kidney, skeletal, smooth and cardiac muscle, glandular tissue and adrenal gland were examined for the presence of viral RNA by in situ hybridization with digoxigenin-labelled riboprobes.
Foci of L10 infection were clearly visible in skeletal muscle ®bres on PID 4 ( Figure 4F ), in one mouse an isolated infected spleen cell was observed and in another a focus of infection in heart muscle (PID 2). All other peripheral tissues were negative for viral RNA. No evidence of SFV infection was detected in peripheral tissues taken from A7(74) infected adult mice on PID 2. However, adult mice administered GSTM or GSTG prior to infection with A7(74), had obvious peripheral sites of infection. Viral RNA was observed in myocytes in the heart (GSTM and GSTG) and rarely within cells in the spleen (GSTG) and the salivary gland (GSTG). Strikingly, pancreatic tissue from pre-treated mice was laden with viral RNA (GSTM and GSTG: see Figure 4E ). No evidence of A7(74) infection was observed in any other peripheral tissue from pretreated mice, including skeletal muscle. Sections of pancreas were further examined for viral protein expression and apoptosis of infected cells ( Figure  4G and H). Viral antigen expression was observed in the acinar cells of the exocrine pancreas. Apoptotic nuclei were seen adjacent to infected cells ( Figure  4H ).
Gold' coloured deposits were observed in the kidneys of mice administered GSTM, but not in mice administered GSTG.
Discussion
Here we demonstrate that the gold (I) moiety in GSTM and GSTG potentiates A7(74) infection of CNS cells, and of acinar cells in the exocrine pancreas, since both GSTM and GSTG enhance the replication and spread of A7(74) within these organs while the thiomalic acid component of GSTM by itself has no potentiating effect. GSTM when administered alone, was more toxic for mice than GSTG alone. In addition, although both compounds enhanced A7(74) replication to similar extents, mortality was lower with GSTG and A7(74). It is possible that the glucose ligand in GSTG lends to more ef®cient cellular uptake and better dissemination of the drug throughout the body. This would be consistent with the higher brain virus titers in GSTG treated mice on PID 4 (Figure 2 ) and the gold coloured deposits observed in the kidneys of GSTM but not GSTG treated mice. The exact cause of death in the gold (I) treated and A7(74) infected mice is not known. Mortality may result from an additive effect of drug and virus, but is clearly not associated with neuronal loss within the brain. Death may have resulted from neuronal dysfunction due to high virus load or to perturbation of pancreatic or cardiac function due to the altered course of the peripheral infection.
Replication of SFV is intimately associated with smooth membrane vesicles in the cytoplasm, termed cytopathic vacuoles (CPVs). These are derived from endosomes and lysosomes, and alphavirus RNA synthesis is critically dependent upon continuous lipid synthesis (Peranen et al, 1995; Perez et al, 1991; Kuge et al, 1989; Froshauer et al, 1988) . Gold (I) compounds may increase yields of A7 (74) in vivo by altering the normal balance of intracellular membranes in favour of SFV infection. Evidence in support of this includes the well documented association of gold with intracellular membranes, particularly lysosomal fractions (Lawson et al, 1977; Braas et al, 1986) and the demonstration that GSTM stimulates smooth membrane production in the mouse CNS (Pathak and Webb, 1983; . Mature, postmitotic neurons have a poorly developed system of smooth membrane vesicles. In contrast, differentiating neurons undergoing active synaptogenesis during the ®rst 2 weeks after birth produce large quantities of smooth membrane vesicles which are transported to growing neuronal projections (Dailey and Bridgman, 1993) . Cessation of this growthrelated membranogenesis may be the maturational event responsible for switching A7(74) replication in neurons from productive to restricted, and in doing so, de®ning the age-related virulence of this strain of SFV (Oliver et al, 1997; Oliver and Fazakerley, 1998) . The observation that neuronal processes stained positive for viral antigen in aurothiolate pre-treated A7(74) infected and in L10 infected brain sections, whereas in A7(74) infected brain sections from non pre-treated mice, only cell bodies stained positive for viral antigens ( Figure 4A ± C), points to a mechanism which involves enhanced intracellular transport of viral material.
Gold (I) compounds have been used therapeutically in the management of rheumatoid arthritis. The desire to understand their therapeutic effects has lead to important insights into their biological chemistry. The spectrum of biological effects is wide and fundamentally dependent on the ability of these compounds to undergo ligand-exchange reactions with thiol groups on cysteine residues in proteins. Gold (I) compounds exert effects on various components of the immune system (Griem et al, 1995; Koike et al, 1994) and the potentiation of the infection could result from an immunomodulatory effect. Our previous studies demonstrating that CNS infection with A7(74) remains restricted in adult SCID mice Amor et al, 1996) would argue against an effect of gold (I) on speci®c immune responses. Furthermore, the pattern of infection in peripheral tissues is different in gold (I) treated mice to that seen in SCID mice. However, other mechanisms including an effect on NK cells or an effect on soluble factors such as interferons, cytokines or growth factors produced by CNS cells cannot be ruled out and remain important possible mechanisms through which the aurothiolates exert their effect.
Potent effects of gold (I) compounds have been observed on transcription factors. It has been proposed that in biological systems, gold (I) has strongest af®nity for cysteine (C) residues¯anked by basic lysine (K) and arginine (R) residues (KCR context), which would render the DNA binding sites of transcription factors such as Jun and Fos preferential targets (Handel et al, 1995) . Sequences similar to the KCR motif occur in other transcription factors, including NF-kB, which is involved in the transcription of numerous genes (Grilli et al, 1993) .
In the maturing neurons of the neonatal mouse brain both A7(74) and L10 infection can result in apoptotic cell death (Allsopp et al, 1998) . In the adult mouse where A7(74) replication is restricted Fazakerley et al, 1993; Oliver et al, 1997) and where in the absence of immune responses, virus can persist for long periods in individual scattered cells (Fazakerley and Webb, 1987a; Amor et al, 1996) , there is minimal apoptotic death (Fazakerley et al, unpub- riboprobe) in peripheral tissues: (F) skeletal muscle infected with SFV L10 (PID 4), (G) virus laden pancreas from an SFV A7(74) infected mouse pre-treated with GSTM. Infection was predominantly in acinar cells of the exocrine pancreas (arrows). (H) section of pancreas immunostained for SFV capsid protein (brown) and TUNEL stained for apoptotic nuclei (blue); counterstained with methyl green. lished results). An age-related change in neuronal susceptibility to Sindbis virus induced apoptosis has also been observed (Lewis et al, 1996) . Despite the increased A7(74) virus load and the increased number of infected cells in the CNS of aurothiolate pretreated (3 ± 4-week-old) mice, infected cells were not TUNEL-positive nor did they show any morphological changes consistent with apoptosis. Thus despite the widespread and productive nature of the A7(74) infection in neurons of the aurothiolate treated mice, these mature neurons remained refractory to apoptotic cell death, at least over the period of the study.
Both GSTM and GSTG altered the pattern of A7(74) infection in peripheral tissues. While skeletal muscle ®bres are the major site of L10 infection in the periphery, with discrete foci also observed in myocytes, aurothiolate-enhanced A7(74) replication showed little evidence of skeletal muscle involvement. In aurothiolate treated infected mice, small foci of A7(74) infection were observed in myocytes and rarely, spleen cells but most striking was the heavy infection of pancreatic tissue. This was most pronounced in pancreatic acinar cells. These cells are particularly rich in intracellular membranes and are highly active in terms of intracellular membrane transport. A 500-fold enhancement of coxsackievirus B3 titer in the pancreas of GSTM treated mice has previously been reported (Kabiri et al, 1978) . Although picornaviruses are not enveloped, their replication is critically dependent on the availability of intracellular smooth membranes and on lipid biosynthesis (Guinea and Carrasco, 1990; Caliguiri and Tamm, 1970) . The coxsackie virus data is therefore consistent with gold (I)-enhancement of virus replication operating through effects on intracellular membrane biochemistry.
Gold (I)-induced alterations in intracellular smooth membrane biochemistry seem most likely to play a pivotal role in the enhancement of A7 (74) replication. However, the potential for altered gene expression in other systems and, or immunomodulatory effects on soluble mediators such as cytokines and growth factors or NK cells must also be considered. It will be important to carry out further studies to elucidate the exact mechanisms involved and it is hoped this will further illuminate the requirements and restraints for virus infections of mature differentiated neurons.
Materials and methods
Virus
The A7(74) and L10 strains of Semliki Forest virus (SFV) were as described previously . Plaque assays were performed on 80% con¯uent BHK cell monolayers in 6-well tissue culture plates (Falcon, Beckton Dickinson Labware) as described previously .
Mice and gold treatment Three-to four-week-old, speci®c pathogen-free, female Balb/c mice were obtained from OLAC (UK). Mice were inoculated ip with 5610 3 plaque forming units (p.f.u.) of virus, in 0.1 ml phosphate buffered saline (PBS) containing 0.75% bovine serum albumin. Ten mg doses of sodium aurothiomalate (GSTM; Myocrisin; May & Baker, England) or aurothioglucose (GSTG; Sigma) were administered ip to 3 ± 4-week-old mice 3 ± 4 h prior to infection with the A7(74) strain of SFV. Control mice were administered 10 mg of thiomalic acid (TMA; Sigma) ip. GSTM was obtained as a 100 mg/ ml solution and GSTG was dissolved to 100 mg/ml in sterile distilled water. TMA was dissolved to 100 mg/ml in sterile distilled water and the pH adjusted to 6.9 ± 7.2 with 4.4% sodium bicarbonate.
Sampling and tissue processing
Mice were killed by ether anaesthesia. Brains were removed and one half frozen immediately and stored at 7708C for virus titer determination while the other was ®xed in 10% neutral phosphatebuffered formalin.
In situ hybridization In situ hybridization was performed on 5 mm sagittal sections of paraf®n embedded brain sections cut onto poly-L-lysine (Sigma) or Biobond (British BioCell International) coated glass slides. Riboprobes were transcribed in vitro with T7 polymerase (using a riboprobe Gemini kit; Promega) from HincII linearized pGEM1-SFV (a kind gift from Dr H Garoff, Karolinska Institute, Sweden). As a control, some sections were hybridized with a riboprobe to the P1 region of the unrelated Theiler's virus. Probes were hydrolyzed in 0.04 M NaHCO 3 (30 min, 608C) prior to use. In situ hybridization with 35 S-labelled riboprobes was carried out as detailed previously (Fazakerley et al, 1991 . In situ hybridization with digoxigenin-labelled riboprobes was performed as detailed in Oliver et al (1997) .
Autoradiographic images of sections hybridized with 35 S-labelled riboprobes were produced by exposure of air dried sections to Hyper®lm bmax (Amersham, UK). The sections were subsequently dipped in photographic emulsion (Amersham, LM-1, diluted with 0.66 M NH 4 acetate) and exposed, usually for 7 days, at 48C. Sections were counterstained with hematoxylin and eosin and examined by bright and dark ®eld microscopy.
Immunostains
Paraf®n embedded tissue sections were dewaxed in xylene, permeabilized with 0.3% Triton X-100 and proteinase K treated as detailed previously (Fazakerley et al, 1991 . After blocking with 10% new-born goat serum, viral proteins were detected in paraf®n embedded tissue sections, using a monospeci®c rabbit antipeptide antisera speci®c for the viral capsid protein; followed by a biotinylated goat anti-rabbit IgG as secondary antibody (Vector Laboratories), an avidin-biotin-peroxidase ampli®-cation step (Vector) and diaminobenzidine (Sigma) as substrate.
Terminal deoxynucleotidyltransferase-mediated dUTP nick end-labelling (TUNEL) Paraf®n embedded tissue sections were dewaxed in xylene and permeabilized with Triton X-100 and proteinase K. One specimen was designated as a positive control, equilibrated with DNase 1 buffer (30 mM Tris pH 7.2; 140 mM sodium cacodylate; 4 mM MgCl 2 ; 0.1 mM dithiothreitol) for 20 min and then incubated in this buffer with 5 mg/ml DNase 1 at 378C for 30 min. After permeabilization the remaining specimens were rinsed with PBS and equilibrated with TUNEL buffer (30 mM Tris pH 7.2; 140 mM sodium cacodylate; 1 mM cobalt chloride) for 20 min. All specimens were incubated with 0.3 U/ml terminal deoxynucleotidlytransferase (TdT); 20 mM Digoxigenin-11-dUTP; 30 mM Tris pH 7.2; 140 mM sodium cacodylate and 1 mM cobalt chloride for 2 h at 378C in a humidi®ed container. As a negative control TdT enzyme was omitted from one reaction. The reaction was terminated with 26SSC for 5 min at room temperature. Incorporated digoxigenin-dUTP was detected by enzyme-linked immunoassay, using an antidigoxigenin alkaline phosphatase conjugate (anti-DIG-AP) to catalyze a colour reaction between 5-bromo-4-chloro-3-indoyl phosphate (X-phosphate) and nitroblue tetrazolium salt (NBT) which deposits a blue precipitate. Specimens were equilibrated with PBS, blocked with 3% normal goat serum (NGS) for 30 min, washed in PBS-T (0.05% Tween 20; 265 min) and incubated with anti-DIG-AP (Boehringer) diluted 1 : 100 in PBS with 1% NGS. The specimens were then washed with PBS (365 min) and incubated with NBT and X-phosphate solutions as detailed in the Boehringer Detection Kit (cat. no. 1175 041). Immunostains for SFV capsid proteins were performed after the TUNEL protocol, as detailed above. Sections were counter stained with methyl green at 608C for 10 min, rinsed in 95% alcohol followed by immersion in 100% alcohol (261 min). Each slide was placed in Histoclear (2615 min) and mounted in Surgimount mounting medium (Surgipath).
